National
Remembering those we lost in 2022
Pioneering artists, designers, actors, and more
The acclaimed LGBTQ people and allies who died in 2022 include:
Jorge Diaz-Johnston, 54, died on Jan. 8. He and his husband were plaintiffs in a lawsuit that led to the legalization of same-sex marriage in Miami-Dade County, the Blade reported.
Andre Leon Talley, 73, the groundbreaking fashion editor, curator, and television personality died on Jan. 18 at a White Plains, N.Y., hospital.
Arnie Kantrowitz, 81, a founding member of the Gay and Lesbian Alliance Against Defamation (now known as GLAAD), died on Jan. 21 at a New York City rehabilitation center from complications of COVID-19.
Spiritual fitness leader Patricia Moreno, 57, died on Jan. 22 at her home in Los Angeles from cervical cancer.
Alan A. Stone, 92, died on Jan. 23 at his Cambridge, Mass., home from laryngeal cancer. When he was president of the American Psychiatric Association, homosexuality was removed from the list of mental disorders.
Genre-busting French designer Thierry Mugler, 73, died on Jan. 23 in his Vincennes home outside Paris.
James Bidgood, 88, an acclaimed gay photographer and filmmaker who anonymously directed the 1971 cult classic “Pink Narcissus,” died on Jan. 31 in Manhattan from complications of COVID-19.
Isabel Torres, 52, the actress best known for her portrayal of Cristina Ortiz Rodriguez, the transgender singer on the series “Veneno” on HBO Max, died on Feb. 11.
Joe Tom Easley, 81, an LGBTQ advocate who played a key role in the effort to repeal ‘Don’t Ask, Don’t Tell,’ died on Feb. 13 at a hospital near his Miami Beach home from complications of lung disease.
Leo Bersani, 90, a scholar of French literature whose work at the height of the AIDS crisis influenced debates about queer identity, died on Feb. 20 at a Peoria, Ariz., assisted-living facility.
Rusty Mae Moore, 80, a transgender educator and activist died on Feb. 23 at her home in Pine Hill, N.Y. from cardiovascular complications.
Richard Lipez, 83, who under the pen name Richard Stevenson wrote a groundbreaking series of novels featuring the out gay detective Donald Strachey, died on March 16 of pancreatic cancer at his home in Becket, Mass.
Ashton Hawkins, 84, executive vice president and counsel to the trustees of the Metropolitan Museum of Art, died on March 27 at a White Plains, N.Y., assisted living facility from complications of Alzheimer’s disease.
Richard Howard, 92, a Pulitzer Prize-winning poet, died on March 31 in Manhattan from complications of dementia.
Eric Little, owner of the iconic 17th Street bar JR.’s and the closed gay bar Cobalt died on May 1 in his sleep at his Hollywood, Md., home of unknown causes.
Margot Heuman, 94, a rare Holocaust survivor who spoke of her same-sex relationship in the concentration camps, died on May 11 at a hospital in Green Valley, Ariz.
Urvashi Vaid, 63, leader of the National Gay and Lesbian Task Force during the AIDS crisis who founded a super PAC to promote LGBTQ women in politics, died on May 14 from cancer at a hospital in Manhattan.
Kristine Gebbie, 78, the first U.S. AIDS czar, died from cancer in Adelaide, Australia on May 17.
Jeffrey Escoffier, 79, a renowned scholar who wrote about gay identity and as a New York City public health official directed campaigns on HIV and other issues, died on May 20 from complications from a fall.
Paul Gunther, 65, a champion of art and architecture in New York nonprofit preservation organizations, died on May 29 in a Manhattan hospital from injuries, which authorities said were sustained due to an attempted suicide, The New York Times reported.
Ronni Solbert, 96, a children’s illustrator most known for her illustrations for “The Pushcart War” written by her partner Jean Merrill, died on June 9 at her Randolph, Vt., home.
Gloria Allen, 76, a transgender activist whose work with at-risk transgender Chicago youth inspired the documentary “Mama Gloria” and the play “Charm,” died on June 13 at her home from respiratory failure.
Clela Rorex, 78, who, in 1975, as a groundbreaking Boulder County, Colo., clerk issued a marriage license to a same-sex couple, died on June 19 from complications of an infection at a Longmont, Colo. hospice.
David Pichette, an ordained Roman Catholic priest who for many years was involved with the LGBTQ Catholic organizations Dignity Washington and Dignity Northern Virginia, died on June 27 from complications of pancreatic cancer at a Boynton Beach, Fla. hospice.
Poet and writer of opera librettos and musicals Kenward Elmslie, 93, died on June 29 at his New York City home.
Gay journalist Chuck Colbert, 67, who covered the Catholic clergy sexual abuse scandal died on June 30.
Noah Vincent, lesbian, journalist and author of the well-regarded book “Self-Made Man” about passing as a man died on July 6 at a clinic in Switzerland. Her death was medically assisted (a voluntarily assisted death).
Computer programmer and art collector John Camp, 77, died on July 12 at an Arlington, Va. hospital from complications of prostate cancer.
Pat Carroll, 95, the game show and sit-com star who reinvented herself in a one-woman show on Gertrude Stein, died on July 31 at her Cape Cod, Mass. home from pneumonia.
Author, poet and activist Elana Dykewomon, 72, died on Aug. 7 at her Oakland, Calif. home from esophageal cancer.
Queer ally, pop singer and “Grease” star Olivia Newton-John, 73, died on Aug. 8 at her Southern California ranch. No cause of death was given. She had lived with breast cancer since 1992.
Actress Anne Heche, 53, died on Aug. 14 from injuries sustained in a car accident.
Stephen Peter Gorman, 69, who once served as chair of the D. C. Mayor’s Committee on Persons with Disabilities, died on Aug. 19 in Washington, D.C.
Founder of the Chelsea Theater Center Robert Kalfin, 89, died on Sept. 20 at a Southampton, N.Y. hospice from myeloid leukemia.
D.C. LGBTQ rights advocate and events promoter Jacob Pring, 47, died on Sept. 26 at his Springfield, Va. home.
Celebrated D.C. LGBTQ activist Kathleen Joan DeBold, 66, died suddenly on Oct. 9 in Ocean City, Md.
Queer icon and legendary star of stage, screen, and TV Angela Lansbury, 96, died on Oct. 10.
Max Woodward, 76, who retired in 2016 as Kennedy Center vice president of theater programming, died on Oct. 14 at a Washington, D.C. care facility from complications from Alzheimer’s disease.
Leslie Jordan, 67, an actor known for his work on “Will & Grace” whose pandemic Instagram postings went viral, died on Oct. 24 in Los Angeles after a car accident.
Gay country music pioneer Patrick Haggerty, 78, died on Oct. 31 at his home in Bremerton, Wash. He had suffered a stroke on a flight after a show on Sept. 30.
Harry Bates, 95, an acclaimed architect who designed houses on Fire Island and the Hamptons, died on Nov. 1 at a hospital in Fernandina Beach, Fla.
Doris Grumbach, 104, acclaimed author who wrote about the plight of women, died on Nov. 4 at a retirement community in Kennett Square, Pa.
Kevin Conroy, 66, the voice of Batman for three decades, died on Nov. 10 from intestinal cancer.
Frederick Swann, 91, a renowned master of the pipe organ died from cancer at his home in Palm Desert, Calif. on Nov. 13
Barbara Love, 85, a feminist and gay rights activist, died on Nov. 13 in the Bronx, N.Y. from complications of leukemia and Parkinson’s disease.
Don Luce, 88, an activist who helped to end the Vietnam War, died on Nov. 17 at a Niagara Falls, N.Y. hospital after suffering a sudden cardiac ischemia.
Ned Rorem, 99, renowned composer of music and diary writer, died on Nov. 18 at his home in Manhattan.
Marijane Meaker, 95, the lesbian author whose 1952 novel “Spring Fire” brought lesbian pulp fiction into the mainstream, died on Nov. 21 at her East Hampton, N.Y. home from cardiopulmonary arrest.
Irene Cara, 63, queer icon, singer and star of “Fame” and “Flashdance,” died on Nov. 26 at her Largo, Fla. home.
Former Republican Congressman James (Jim) Kolbe, 80, who represented Southern Arizona in Congress for 22 years, died on Dec. 3 from a stroke. He was the first openly gay Republican member of the House of Representatives.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Protecting the trans community is not optional for elected allies and candidates
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
